Researchers at Kobe University have developed an AI system that can detect acromegaly, a rare hormone disorder, by analyzing photos of the back of the hand and a clenched fist. The disease often develops slowly and can take years to diagnose, even though untreated cases may shorten life expectancy.
A generative AI system can now analyze blood cells with greater accuracy and confidence than human experts, detecting subtle signs of diseases like leukemia. It not only spots rare abnormalities but also recognizes its own uncertainty, making it a powerful support tool for clinicians.
Stanford researchers have developed an AI that can predict future disease risk using data from just one night of sleep. The system analyzes detailed physiological signals, looking for hidden patterns across the brain, heart, and breathing. It successfully forecast risks for conditions like cancer, dementia, and heart disease. The results suggest sleep contains early health warnings doctors have largely overlooked.
AI tools designed to diagnose cancer from tissue samples are quietly learning more than just disease patterns. New research shows these systems can infer patient demographics from pathology slides, leading to biased results for certain groups. The bias stems from how the models are trained and the data they see, not just from missing samples. Researchers also demonstrated a way to significantly reduce these disparities.
A newly developed AI can predict which diseases specific genetic mutations are likely to cause, not just whether they are harmful. The breakthrough could speed up diagnoses and open new paths for personalized treatment.
Researchers at the University of Surrey developed an AI that predicts what a person’s knee X-ray will look like in a year, helping track osteoarthritis progression. The tool provides both a visual forecast and a risk score, offering doctors and patients a clearer understanding of the disease. Faster and more interpretable than earlier systems, it could soon expand to predict other conditions like lung or heart disease.
A new AI tool called DOLPHIN exposes hidden genetic markers inside single cells, enabling earlier detection and more precise treatment choices. It also sets the stage for building virtual models of cells to simulate disease and drug responses.
Scientists at Mount Sinai have created an artificial intelligence system that can predict how likely rare genetic mutations are to actually cause disease. By combining machine learning with millions of electronic health records and routine lab tests like cholesterol or kidney function, the system produces "ML penetrance" scores that place genetic risk on a spectrum rather than a simple yes/no. Some variants once thought dangerous showed little real-world impact, while others previously labeled uncertain revealed strong disease links.